Rajaei Cardiovascular, Medical & Research Center
Tehran, Iran
NCT Number: NCT01948453
The purpose of this study is to determine whether garlic in adjunct to conventional medical treatment is effective in improving carotid intima media thickness (CIMT), Flow mediated dilation (FMD) and plasma lipid profile or c-reactive protein of coronary artery disease (CAD) patients.
Looking for future studies?
Notify Me25 year–75 year
All sexes
Interventional
Not applicable
Tehran, Iran
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Change in type of medication during study
Garlic tablet in adjunct to medical treatment
Time frame: 12 weeks
Change from baseline and compared to placebo group in Carotid Intima Media Thickness at 12 weeks
Time frame: 12 weeks
Change from baseline and compared to placebo group in Flow-mediated dilatation at 12 weeks
Time frame: 12 weeks
Change from baseline in plasma levels at 12 weeks
Shahid Beheshti University
Other
Effect of Garlic Tablet on Carotid Intima Media Thickness and Flow-mediated Dilation in Patients Undergoing Angioplasty
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsNCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial DetailsNCT04058990
Arterial Occlusive Diseases, Arteriosclerosis
Kitakyushu, Fukuoka, Japan
View Trial Details